 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
|
Orlando, FL
Scarborough, ME
Edison, NJ
Pittsburgh, PA
Dallas, TX |
|
07/01/2009 |
|
|
|
|
|
Details |
|
Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme |
|
Los Angeles, CA
Atlanta, GA
New York, NY |
|
06/30/2009 |
|
|
|
Details |
|
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
|
Los Angeles, CA
Stanford, CA
Chicago, IL
Lebanon, NH
New York, NY |
|
06/30/2009 |
|
|
|
|
|
Details |
|
A Phase 2 Study of XL184 in Subjects with Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse |
|
San Francisco, CA
Charlottesville, VA |
|
06/29/2009 |
|
|
|
Details |
|
Phase II Clinical Trial of Hyperbaric Oxygenation in Conjunction with Radiotherapy and Temozolomide in Adults with Newly Diagnosed Glioblastoma |
|
Mineola, NY |
|
06/18/2009 |
|
|
|
|
|
Details |
|
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
|
Birmingham, AL
Tampa, FL
Atlanta, GA
Boston, MA
Baltimore, MD
Bethesda, MD
Detroit, MI
Winston-Salem, NC
Cleveland, OH
Philadelphia, PA |
|
04/21/2009 |
|
|
|
|
|
Details |
|
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
|
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
Details |
|
A Phase II Trial of Bevacizumab (avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)
|
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
|
|
Details |
|
A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas
|
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
Details |
|
Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma |
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
|
|
Details |
|
A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
|
Toronto, Ontario, CANADA
Bethesda, MD
New York, NY
Cincinnati,, OH
Columbus, OH |
|
04/21/2009 |
|
|
|
Details |
|
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma |
|
Bethesda, MD |
|
04/15/2009 |
|
|
|
|
|
Details |
|
Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
|
Houston, TX |
|
04/14/2009 |
|
|
|
Details |
|
A Phase II trial of RAD001 in patients with recurrent glioblastoma multiforme (Study # CRAD001C2410 |
|
Cincinnati, OH |
|
04/06/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Cincinnati, OH |
|
04/06/2009 |
|
|
|
Details |
|
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas |
|
San Francisco, CA |
|
04/06/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Cincinnati, OH |
|
04/06/2009 |
|
|
|
Details |
|
Phase III Randomized, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Subjects to Compare the Efficacy of AZD2171 [RECENTIN] Monotherapy and the Combination of AZD2171 with Lomustine to the Efficacy of Lomustine Alone |
|
Cincinnati, OH |
|
04/06/2009 |
|
|
|
|
|
Details |
|
Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma |
|
Houston, TX |
|
04/03/2009 |
|
|
|
Details |
|
Phase II study of CDX-110 with radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme |
|
Houston, TX |
|
04/03/2009 |
|
|
|
|
|
Details |
|
Phase III, randomised, parallel Group, multi-centre study in recurrent glioblastoma patients to compare the efficacy of cediranib monotherapy and the combination of cediranib with lomustine to the efficacy of lomustine alone |
|
Houston, TX |
|
04/03/2009 |
|
|
|
Details |
|
Phase I Pilot Study of HLA-A2-Restricted Synthetic Glioma Antigen Peptide Vaccine and Poly ICLC Vaccine in Young Patients With Newly Diagnosed Malignant or Intrinsic Brain Stem Glioma, Incompletely Resected Non-Brainstem High-Grade Glioma, or Recurrent Unresectable Low-Grade Glioma |
|
Pittsburgh, PA |
|
03/16/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Los Angeles, CA
Tampa, FL
Chicago, IL
Ann Arbor, MI
Minneapolis, MN
Summit, NJ
Rochester, NY
Cleveland, OH
Columbus, OH
Dallas, TX |
|
03/15/2009 |
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Los Angeles, CA
Tampa, FL
Durham, NC
Omaha, NE
New York, NY |
|
03/04/2009 |
|
|
|
|
|
Details |
|
A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 (MAb-425) in High Grade Gliomas |
|
Philadelphia, PA |
|
02/12/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Los Angeles, CA
Los Angeles, CA
Orange, CA
Palo Alto, CA
San Francisco, CA
San Francisco, CA
New Haven, CT
Gainsville, FL
Jacksonville, FL
Atlanta, GA
Iowa City, IA
Chicago, IL
Chicago, IL
Evanston, IL
Boston, MA
Baltimore, MD
Detroit, MI
Lansing, MI
Saginaw, MI
Durham, NC
Hackensack, NJ
Buffalo, NY
New York, NY
New York, NY
New York, NY
Syracuse, NY
Cleveland, OH
Cleveland, OH
Columbus, OH
Philadelphia, PA
Houston, TX
San Antonio, TX
Salt Lake City, UT
Charlottesville, VA
Seattle, WA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
A Phase II study of Bevacizumab (Avastin?) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma |
|
San Francisco, CA |
|
01/09/2009 |
|
|
|
Details |
|
NABTC05-02 - Phase I/II Studies of BAY 43-9006 (sorafenib) in Combination with OSI-774 (erlotinib), R115777 (tipifarnib) or CCI-779 (temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma. |
|
San Francisco, CA |
|
01/09/2009 |
|
|
|
|
|
Details |
|
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
|
Santa Monica, CA |
|
11/29/2008 |
|
|
|
Details |
|
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
|
|
Cleveland, OH
Cleveland, OH |
|
11/19/2008 |
|
|
|
|
|
Details |
|
Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
|
|
San Francisco, CA
Washington, DC
Chicago, IL
Boston, MA
Bethesda, MD
Durham, NC
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Seattle, WA |
|
11/08/2008 |
|
|
|
Details |
|
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
|
Houston, TX |
|
10/27/2008 |
|
|
|
|
|
Details |
|
Phase I study of MPC-6827 in combination with carboplatin for recurrent glioblastoma |
|
Houston, TX |
|
10/27/2008 |
|
|
|
Details |
|
Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/27/2008 |
|
|
|
|
|
Details |
|
BIBW 2992 with or without daily temozolomide in the treatment of
patients with recurrent malignant glioma
|
|
Charlottesville, VA |
|
10/20/2008 |
|
|
|
Details |
|
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
|
|
Boston, MA
New York, NY
Houston, TX
Charlottesville, VA |
|
10/09/2008 |
|
|
|
|
|
Details |
|
CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan |
|
Boston, MA
Durham, NC
New York, NY
Charlottesville, VA |
|
10/09/2008 |
|
|
|
Details |
|
Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma and CMV Infection |
|
Solna, Stockholm, Sweden
Umea, Sweden
Uppsala, Sweden |
|
10/09/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of Sorafenib and Temsirolimus (CCI-779) in Patients With Recurrent Glioblastoma |
|
Scottsdale/Phoenix, AZ
Jacksonville, FL
Rochester, MN
Bismarck, ND
Charlottesville, VA |
|
10/09/2008 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Charlottesville, VA |
|
09/30/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Charlottesville, VA |
|
09/30/2008 |
|
|
|
Details |
|
AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors |
|
Cleveland, OH |
|
09/28/2008 |
|
|
|
|
|
Details |
|
A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme
|
|
Toronto, Ontario, CANADA |
|
09/28/2008 |
|
|
|
Details |
|
Gliogene: An International Brain Tumor Study |
|
Houston, TX |
|
07/24/2008 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
05/28/2008 |
|
|
|
Details |
|
Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma |
|
Houston, TX |
|
05/28/2008 |
|
|
|
|
|
Details |
|
Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme |
|
Boston, MA
Durham, NC
New York, NY |
|
04/27/2008 |
|
|
|
Details |
|
Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme |
|
Houston , TX |
|
04/27/2008 |
|
|
|
|
|
Details |
|
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Phase 2, 2-part, multicenter, open-label study to evaluate the safety, tolerability, and efficacy of CT-322 (Angiocept™) monotherapy and combination therapy with irinotecan in patients with recurrent glioblastoma multiforme
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients with Recurrent Malignant Glioma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Los Angeles, CA
Boston, MA
Durham, NC
New York, NY
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
Houston, TX
San Antonio, TX
Madison, WI |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Mobile, AL
Loma Linda, CA
Pomona, CA
Sacramento, CA
Sacramento, CA
Lewes, DE
Newark, DE
Newark, DE
Jacksonville, FL
Tampa, FL
Columbus, GA
Honolula, HI
Boise, ID
Chicago, IL
Harvey, IL
Maywood, IL
South Bend, IN
South Bend,, IN
Annapolis, MD
Detroit, MI
Royal Oak, MI
Edina, MN
Minneapolis, MN
Robbinsdale, MN
Saint Louis Park, MN
Cape Girardeau, MO
Joplin, MO
Kansas City, MO
Saint Louis, MO
Springfield, MO
St Louis, MO
Goldsboro, NC
Minot, ND
Omaha, NE
Concord, NH
Lebanon, NH
Long Branch,, NJ
Marlton, NJ
Toms River, NJ
Voorhees, NJ
Rochester, NY
Syracuse, NY
, OH
Akron, OH
Akron, OH
Akron, OH
Canton, OH
Chillicothe, OH
Cleveland, OH
Columbus, OH
Columbus, OH
Columbus, OH
Wooster, OH
Zanesville, OH
Tulsa, OK
Allentown, PA
Bethlehem, PA
Bryn Mawr, PA
Paoli, PA
Philadelphia, PA
Philadelphia, PA
Philadelphia, PA
Reading, PA
Wynnewood, PA
Charleston, SC
Greenville, SC
Greenville, SC
Rapid City, SD
Kingsport, TN
Kingsport, TN
Galveston, TX
Lubbock, TX
Temple, TX
Murray, UT
Ogden, UT
Provo, UT
Saint George, UT
Salt Lake City, UT
Burlington, VT
Bellingham, WA
Yakima, WA
Green Bay, WI
La Crosse, WI
Madison, WI
Menomonee Falls, WI
Milwaukee, WI
Racine, WI |
|
04/11/2008 |
|
|
|
Details |
|
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery |
|
Durham, NC |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-Specific T-Cell Adoptive Transfer [ERaDICATe] |
|
Durham, NC |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma) |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
|
San Francisco, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
A phase I/II Evaluation of Vaccination with Type-1 Dendritic Cells Pulsed With Multiple Peptides In the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas |
|
Pittsburgh, PA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Study of Intratumoral and/or Resection Cavity Administration of Recombinant Measles Virus Encoding Human Carcinoembryonic Antigen in Patients With Recurrent Glioblastoma Multiforme |
|
Rochester, MN |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Gliogene: Brain Tumor Linkage Study |
|
San Francisco, CA
Tampa, FL
Boston, MA
New York, NY
Houston, Tx |
|
01/17/2008 |
|
|
|
Details |
|
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
|
San Francisco, CA |
|
01/17/2008 |
|
|
|
|
|
Details |
|
High dose erlotinib for recurrent/residual GBM; Correlation of response to EGFRvIII and PTEN status |
|
New York, NY |
|
11/08/2007 |
|
|
|
Details |
|
NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
Phase I/II trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine For Patients With Recurrent High Grade Glioma |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
Los Angeles, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/03/2007 |
|
|
|
|
|
Details |
|
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
|
Duarte, CA
Baltimore, MD |
|
08/31/2007 |
|
|
|
Details |
|
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
|
Philadelphia, PA
Philadelphia, PA
Charleston, SC |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase IIa Safety and Light Dose-Escalation Study in Patients With Primary or Recurrent/High-Grade Glioma (Defined for the Purposes of the Protocol as Anaplastic Astrocytoma [AA] or Glioblastoma Multiforme [GBM]) Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma |
|
, Serbia |
|
08/26/2007 |
|
|
|
Details |
|
A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients |
|
Toronto, Ontario, CANADA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Phase 1/2 Study of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
, |
|
08/26/2007 |
|
|
|
Details |
|
Phase I Study of Enzastaurin and Temozolomide in Patients With Gliomas |
|
Glasgow, Scotland, UK |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status |
|
Boston, MA |
|
08/26/2007 |
|
|
|
Details |
|
Phase II Study: Systemic Treatment With iv ZK219477-Epothilone in Recurrent Glioblastoma Patients |
|
Milan, Italy |
|
08/26/2007 |
|
|
|
|
|
Details |
|
The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-Grade Astrocytomas |
|
Bergen, Norway |
|
08/26/2007 |
|
|
|
Details |
|
A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors |
|
NEW YORK CITY, NY |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma |
|
Durham, NC |
|
08/20/2007 |
|
|
|
Details |
|
A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas |
|
Vista, CA |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas |
|
Chicago, IL |
|
08/20/2007 |
|
|
|
Details |
|
Determination of the In-Tumor-Concentration of Imatinib Mesylate (Gleevec) in Malignant Glioma After Oral Administration |
|
Baltimore, MD |
|
08/20/2007 |
|
|
|
|
|
Details |
|
Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms |
|
New York, NY |
|
08/20/2007 |
|
|
|
Details |
|
A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme |
|
Los Angeles, CA
Chicago, IL
Boston, MA
Durham, NC |
|
08/19/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Los Angeles, CA
Boston, MA
Boston, MA
Boston, MA
New York, NY |
|
08/19/2007 |
|
|
|
Details |
|
Phase II Study of Dose Intensive Temozolomide (Temodar) in Elderly Adults With Newly Diagnosed Glioblastoma |
|
Seattle, WA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
Phase II Trial of Intralesional Adoptive Cellular Therapy of Glioblastoma With Interleukin-2-Stimulated Lymphocytes |
|
Newport Beach, CA |
|
08/19/2007 |
|
|
|
Details |
|
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel® in Subjects With Recurrent Glioma |
|
Chicago, IL
Baltimore, MD
Chapel Hill, NC
Nashville, TN |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of Bevacizumab (Avastin) in Combination With Metronomic Temozolomide (Temodar)for Recurrent Malignant Glioma |
|
Durham, NC |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy |
|
Copenhagen, Denmark |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors |
|
Winston-Salem, NC |
|
08/18/2007 |
|
|
|
Details |
|
Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme |
|
Houston, TX |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma. |
|
Los Angeles, CA
Durham, NC |
|
08/18/2007 |
|
|
|
Details |
|
Phase II Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients with Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
The use of the Gliasite radiation therapy system for malignant gliomas |
|
Philadelphi, PA |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma |
|
New York, NY |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of Dendritic Cell Vaccine Pulsed with Tumor Lysate Followed by Temozolomide Upon Recurrence in Patients with Newly Diagnosed Glioblastoma |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas. |
|
Montreal, Canada |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Brain Mapping for Brain Tumors |
|
Boston, MA |
|
08/18/2007 |
|
|
|
Details |
|
Functional image guided removal of brain tumors |
|
Manhasset, NY |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Gliadel and Dendritic Cell Vaccine for Malignant Glioma |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
Improving Quality Of Life For Brain Tumor Patients |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase 1 Trial Gamma Knife For Primary Brain Tumors - Gliomas. |
|
Birmingham, AL |
|
08/18/2007 |
|
|
|
Details |
|
Phase I Study Of Pioglitazone And Isotretinoin In Patients With Recurrent Or Progressive Malignant Gliomas |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Pilot Study of Bevacizamab in Patients with Recurrent or Progressive Primary Brain Tumors |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
Open-label, Dose Confirmation and Dosimetry Study of Interstitial 131-I chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme (GBM) |
|
Tustin, CA |
|
07/31/2007 |
|
|
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Birmingham, AL
Chicago, IL
Cambridge, MA
Grand Rapids, MI
Dallas, TX |
|
06/04/2007 |
|
|
|
Details |
|
A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection |
|
Cincinnati , OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Birmingham, AL
Tampa, FL
Boston, MA
Baltimore, MD
Detroit, MI
Winston-Salem, NC
Cleveland, OH
Philadelphia, PA |
|
05/01/2007 |
|
|
|
Details |
|
Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma |
|
Tampa, FL
Atlanta, GA
Chicago, IL
Boston, MA
Detroit, MI
Durham, NC
Cleveland, OH |
|
05/01/2007 |
|
|
|
Details |
|
Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
|
Birmingham, AL
Tampa, FL
Atlanta, GA
Boston, MA
Baltimore, MD
Detroit, MI
Winston-Salem, NC
Cleveland, OH
Philadelphia, PA |
|
05/01/2007 |
|
|
|
Details |
|
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
|
Detroit, MI |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma |
|
Cleveland, OH
Columbus, OH
Portland, OR |
|
05/01/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Birmingham, AL
Phoenix, AZ
Phoenix, AZ
Downey, CA
Long Beach, CA
Los Angeles, CA
Sacramento, CA
Denver, CO
Jacksonville, FL
St. Petersburg, FL
West Palm Beach, FL
Atlanta, GA
Augusta, GA
Honolulu, HI
Iowa City, IA
Chicago, IL
Park Ridge, IL
New Orleans, LA
Boston, MA
Baltimore, MD
Scarborough, ME
Grand Rapids, MI
Kansas City, MO
Saint Louis, MO
Saint Louis, MO
Omaha, NE
Hackensack, NJ
Summit, NJ
Las Vegas, NV
Brooklyn, NY
New Hyde Park, NY
New York, NY
Rochester, NY
Valhalla, NY
Cleveland, OH
Cleveland, OH
Dayton, OH
Pittsburgh, PA
Knoxville, TN
Memphis, TN
Dallas, TX
Fort Worth, TX
Houston, TX
Lubbock, TX
San Antonio, TX
Falls Church, VA
Roanoke, VA
Burlington, VT
Milwaukee, WI
Huntington, WV |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Birmingham, AL
Tampa, FL
Atlanta, GA
Boston, MA
Baltimore, MD
Detroit, MI
Winston-Salem, NC
Philadelphia, PA |
|
04/29/2007 |
|
|
|
Details |
|
Boswellia Serrata Combined With a Low-Fat, Vegan Diet or a Standard Diet Alone in Treating Patients Who Have Undergone Surgery and Radiation Therapy for Newly Diagnosed Glioblastoma Multiforme |
|
Cleveland, OH |
|
04/28/2007 |
|
|
|
|
|
Details |
|
Clinical and Molecular-Metabolic Trial of Perifosine for Recurrent/Progressive Malignant Gliomas |
|
New York, NY |
|
04/15/2007 |
|
|
|
Details |
|
Combination Therapy With Thalidomide and CPT-11 in Patients With Recurrent Anaplastic Gliomas or Glioblastoma Multiforme |
|
Houston , TX |
|
04/15/2007 |
|
|
|
|
|
Details |
|
Phase I/II Pazopanib Plus Lapatinib for Relapsed Malignant Glioma |
|
Houston, TX |
|
04/15/2007 |
|
|
|
Details |
|
Phase II Study of Erlotinib in Patients With Recurrent or Progressive Glioblastoma Multiforme
|
|
Cleveland, OH |
|
04/15/2007 |
|
|
|
|
|
Details |
|
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma in elderly ( over 69 years old) Patients |
|
Seattle, WA |
|
04/15/2007 |
|
|
|
Details |
|
RTA 744 in Treating Patients With Recurrent or Refractory Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Glioblastoma Multiforme, or Gliosarcoma |
|
Los Angeles, CA
Dallas, TX |
|
11/21/2006 |
|
|
|
|
|
Details |
|
A Phase 2 Multicenter Study of AQ4N in Combination With Radiotherapy and Temozolomide, for Safety, Tolerability, and Activity in Subjects With Newly Diagnosed Glioblastoma Multiforme |
|
Detroit, MI |
|
11/05/2006 |
|
|
|
Details |
|
Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
|
|
New York, NY |
|
10/12/2006 |
|
|
|
|
|
Details |
|
TREATMENT OF NEWLY DIAGNOSED, HIGH-GRADE, MALIGNANT GLIOMA WITH POLIFEPROSAN 20 CONTAINING CARMUSTINE IMPLANT (GLIADEL® WAFER) USING MR SPECTROSCOPY DATA AS A PRIMARY INDICATOR OF THERAPEUTIC RESPONSE |
|
New York, NY |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
,
, Canada
, Canada
, Canada
, Canada
, Canada
, Canada
, Switzerland
, Switzerland
Auckland, New Zealand
Perth, Western Australia, 6001, Australia
Randwick, New South Wales, 2031, Australia
Phoenix, AZ
Downey, CA
Loma Linda, CA
Los Angeles, CA
Los Angeles, CA
Los Angeles, CA
Madera, CA
Oakland, CA
Orange, CA
Orange, CA
Sacramento, CA
San Francisco, CA
Santa Barbara , CA
Travis Air Force Base, CA
Denver, CO
Farmington, CT
Washington, DC
Washington, DC
Wilmington, DE
Atlanta, GA
Macon, GA
Savannah, GA
Des Moines, IA
Chicago, IL
Chicago, IL
Park Ridge, IL
Indianapolis, IN
Springfield, MA
Baltimore, MD
Ann Arbor, MI
Detroit, MI
Grand Rapids, MI
Kalamazoo, MI
Royal Oak, MI
Royal Oak, MI
Minneapolis, MN
Rochester, MN
Kansas City, MO
Chapel Hill, NC
Charlotte, NC
Winston-Salem, NC
Fargo, ND
Omaha, NE
Omaha, NE
Brunswick, NJ
Newark, NJ
Paterson, NJ
Summit, NJ
Las Vegas, NV
Albany, NY
Bronx, NY
Brooklyn, NY
Brooklyn, NY
Brooklyn, NY
Brooklyn, NY
New Hyde Park, NY
New York, NY
Stony Brook, NY
Syracuse, NY
Akron, OH
Cincinnati, OH
Cleveland, OH
Columbus, OH
Dayton, OH
Toledo, OH
Portland, OR
Danville, PA
Philadelphia, PA
Pittsburgh, PA
Sioux Falls, SD
Johnson City, TN
Knoxville, TN
Nashville, TN
Amarillo, TX
Austin, TX
Dallas, TX
Houston, TX
Lubbock, TX
San Antonio, TX
San Antonio, TX
Temple, TX
Norfolk, VA
Seattle, WA
Seattle, WA
Spokane, WA
Tacoma, WA
Green Bay, WI
Green Bay, WI
Green Bay, WI
La Crosse, WI
Madison, WI
Marshfield, WI
Marshfield, WI
Huntington, WV |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Scottsdale/Phoenix, AZ
Jacksonville, FL
Des Moines, IA |
|
08/11/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Birmingham, AL
Scottsdale/Phoenix, AZ
Jacksonville, FL
Cedar Rapids, IA
Des Moines, IA
Missouri Valley, IA
Sioux City, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Rochester, MN
Saint Cloud, MN
Bismarck, ND
Fargo, ND
Lincoln, NE
Allentown, PA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
|
Scottsdale/Phoenix, AZ
Jacksonville, FL
Des Moines, IA
Sioux City, IA
Rochester, MN
Saint Louis Park, MN
Bismarck, ND
Fargo, ND |
|
06/26/2006 |
|
|
|
Details |
|
Phase I/II Study of High Dose Irinotecan (Camptosar, CPT-11) in Patients With Recurrent Unresectable Malignant Glioma on Steroids/Anti-Epileptics |
|
Louisville, KY |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Phoenix, AZ
Jacksonville, FL
Kearney, NE
Vineland, NJ
Akron, OH
Murray, UT
Ogden, UT
Provo, UT
Saint George, UT
Wheeling, WV |
|
05/29/2006 |
|
|
|
Details |
|
Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme |
|
Lebanon, NH |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors |
|
Los Angeles, CA |
|
05/29/2006 |
|
|
|
Details |
|
A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion |
|
Louisville, KY |
|
05/27/2006 |
|
|
|
|
|
Details |
|
Genetic Epidemiology of Adult-Onset Glioma |
|
Louisville, KY |
|
05/27/2006 |
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Washington, DC
Chicago, IL
Boston, MA
Bethesda, MD
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
05/27/2006 |
|
|
|
|
|
Details |
|
Comparative 2-D Tumor Analysis in Familial Gliomas |
|
Edmonton, Alberta, Canada |
|
05/04/2006 |
|
|
|
Details |
|
PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
|
|
Los Angeles, CA
Boston, MA
Ann Arbor, MI
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
05/04/2006 |
|
|
|
|
|
Details |
|
Treatment of Primary Glioblastoma Multiforme With Cetuximab (Erbitux), Radiotherapy and Temozolomide (GERT) – Phase I/II Trial |
|
Heidelberg, Baden-Württemberg, Germany |
|
05/04/2006 |
|
|
|
Details |
|
A Phase I Trial Using Combination Irinotecan (CPT-11) and Thalidomide for Recurrent CNS Tumors |
|
Albuquerque, NM |
|
05/02/2006 |
|
|
|
|
|
Details |
|
A Pilot Study of Dronabinol for the treatment of nausea,vomiting and appetite loss in Adult Patients With Primary Gliomas |
|
Durham, NC |
|
05/01/2006 |
|
|
|
Details |
|
Phase II Study of Pemetrexed Disodium (Alimta) in Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases |
|
Chicago, IL |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Pilot Study of the Safety and Accuracy of Fluorothymidine F 18 Positron Emission Tomography in Detecting Recurrent Disease in Patients With Gliomas
|
|
Seattle, WA |
|
05/01/2006 |
|
|
|
Details |
|
"Head Start" chemotherapy protocol for children less than 10 years old with newly diagnosed high grade primary brain tumors with intent to eliminate irradiation and abbreviate total duration of treatment to 6 months with resultant improved cure rate and quality of survival. |
|
Oakland, CA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without
subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors |
|
Oakland, CA |
|
05/01/2006 |
|
|
|
Details |
|
Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors |
|
Chicago, IL
Bethesda, MD
Durham, NC
Durham, NC
Lincoln, NE
Philadelphia, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Detroit, MI |
|
02/03/2006 |
|
|
|
Details |
|
Iodine I 131 Monoclonal Antibody TNT-1/B (131I MOAB TNT-1/B), in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
|
Detroit, MI |
|
02/03/2006 |
|
|
|
|
|
Details |
|
Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor) |
|
Detroit, MI |
|
02/03/2006 |
|
|
|
Details |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
|
, Austria
Amsterdam, 1007 MB, Netherlands
ESSEN, Germany
Munich, D-81377, Germany
Nice, 06002, France
Petten, NL-1755 ZG, Netherlands
Pisa, 56100, Italy
Toronto, Ontario, Canada |
|
01/08/2006 |
|
|
|
|
|
Details |
|
Phase II trial of Temodar ® plus O6-Benzylguanine in the treatment of patients with Temodar® -resistant malignant glioma.
|
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
Pharmacological intervention for learning impaired children surviving treatment for cancer. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Smithtown, NY |
|
12/03/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery for Brain Tumors |
|
La Jolla, CA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Phase I trial of Temodar plus O6-Benzylguanine plus Irinotecan (CPT-11) in the treatment of patients with recurrent/progressive Cerebral anaplastic gliomas. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
Phase I trial of Temozolomide (Temodar) and O6-Benzylguanine (o6-bg)in pediatric patients with recurrent brain tumors. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
|
|
Details |
|
The use of the Gliasite radiation therapy system for malignant gliomas |
|
Mobile , AL |
|
12/03/2005 |
|
|
|
Details |
|
ZD1839 and Oral Irinotecan in Treating Young Patients with Refractory Solid Tumors |
|
Memphis, TN |
|
12/03/2005 |
|
|
|
|
|
Details |
|
A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors. |
|
New York, NY |
|
12/03/2005 |
|
|
|
Details |
|
Fractionated Stereotactic Radiosurgery plus Topotecan radiation sensitizer in the treatment of recurrent malignant astrocytoma or as consolidation after external beam radiotherapy. |
|
New York, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Fractionated Streotactic Rdaiotherapy boost and Temozolamide in malignant Gliomas |
|
Brooklyn, NY |
|
12/03/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Edison, NJ |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases. |
|
Rockville Centre, NY |
|
12/03/2005 |
|
|
|
Details |
|
Gliadel Wafer Implantation For Malignant Gliomas Of The Brain |
|
Smithtown, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Study of Gliadel in Adults with Recurrent Malignant Gliomas |
|
Baltimore, MD
Detroit, MI
Winston-Salem, NC
Philadelphia, PA |
|
12/03/2005 |
|
|
|
Details |
|
Phase I/II Study of Multiple Light Fiber Interstitial Photodynamic Therapy for Primary and Metastatic Supratentorial Brain Tumors |
|
Hershey, PA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Quality of Life Studies (There are 19 seperate studies listed here) |
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
Use of Epilepsy Monitoring And Electrocorticography For Seizure Control In Patients With Brain Tumors |
|
Hackensack, NJ |
|
12/03/2005 |
|
|
|
|
|
Details |
|
A Phase I/II Study of Reirradiation for Recurrent Pediatric Brain and Spinal Cord Tumors and Primary Glioblastoma Multiforme Using the Photon Radiosurgery System |
|
Chicago, IL |
|
11/27/2005 |
|
|
|
Details |
|
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
|
|
Bethesda, MD |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
|
Los Angeles, CA
Boston, MA
Ann Arbor, MI
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
11/27/2005 |
|
|
|
Details |
|
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors |
|
Portland, OR |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas |
|
Lanne, Switzerland |
|
11/27/2005 |
|
|
|
Details |
|
Melphalan and Mannitol in Treating Patients With Central Nervous System Tumors |
|
Portland, OR |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Gliobastoma Treated With Concurrent Radiation Therapy and Temozolomide |
|
Edmonton, Alberta, Canada |
|
11/27/2005 |
|
|
|
Details |
|
Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme |
|
Toulouse, France |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
|
|
Garden City, NY |
|
11/27/2005 |
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Washington, DC
Chicago, IL
Boston, MA
Durham, NC
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Memphis, TN
Houston, TX
Seattle, WA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas (Brainstem glioma, glioblastoma multiforme, gliosarcoma, anaplastic astrocytoma)
|
|
Baltimore, MD |
|
11/27/2005 |
|
|
|
Details |
|
Computer Assisted Stereotactic Navigation For Resection Of Brain Tumors In Children And Adults |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Double sequential high dose Thiotepa with autologous stem cell rescue for patients age <60 years with recurrent malignant brain cancer. |
|
Los Angeles, CA |
|
11/27/2005 |
|
|
|
Details |
|
Endoscopic ventriculostomy for obstructive hydrocephalus in terminal patients with hydrocephalus and brain tumours. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Feasibility of using oral Etoposide combined with escalating doses of Tamoxifen for children with recurrent gliomas |
|
Denver, CO |
|
11/27/2005 |
|
|
|
Details |
|
Frameless Computer Guided Stereotactic Surgery For Brain Tumors |
|
New York, NY |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Functional brain Mapping Of Motor And Speech Areas For Resection Of Tumors Near Functional Areas Of The Brain |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
Details |
|
Genetic Therapy of meningiomas and gliomas in the Malay population in the NorthnEast coast of Malaysia |
|
Kelantan, Malaysia, MALAYSIA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Longitudinal Neuropsychologic Evaluation And Strategic Educational Interventions. |
|
Houston, TX |
|
11/27/2005 |
|
|
|
Details |
|
Multiple Courses of High Dose Chemotherapy With Peripheral Stem Cell Support in Relapsed, Refractory or Progressive Glial Tumors and in Children With Glioblastoma or Incompletely Resected Anaplastic Astrocytoma at the Time of Diagnosis. |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase 2 Trial of Multi-Agent High Dose Chemotherapy Followed By Stem Cell Rescue For High Grade Gliomas in Adults. |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
Details |
|
Phase 2 Trial of Stereotactic Radiosurgery For Recurrent Pediatric Brain Tumors |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
|
Los Angeles, CA
Los Angeles, CA |
|
11/27/2005 |
|
|
|
Details |
|
Pre- and Postoperative Use of ZD1839(Iressa) in Recurrent Glioblastoma, Including Translational Research |
|
Zürich , Switzerland
Los Angeles, CA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Regulus Navigator for use with a three point pinion - frameless stereotactic surgery |
|
New York, NY |
|
11/27/2005 |
|
|
|
Details |
|
Rehabilitation For Brain Tumor Patients. |
|
Houston, TX |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Risk Adapted, Multimodal Therapy In Newly Diagnosed Supratentorial Malignant Glioma, Stratified To KPS. |
|
Kreischa Dresden, GERMANY |
|
11/27/2005 |
|
|
|
Details |
|
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme |
|
Houston, TX |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Volumetric Stereotactic Procedures |
|
New York, NY |
|
11/27/2005 |
|
|
|
Details |
|
A Phase II Trial of Cisplatinum and Temodar followed by Cranial Irradiation and Temodar in Adults with Newly Diagnosed Glioblastoma Multiforme |
|
Rochester, NY |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Adoptive IL-2 activated LAK cell intratumoral immunotherapy implant with adjuvant radiosurgery boost and naturopathic/nutritional immune enhancement. This is for newly diagnosed patients only.
|
|
Newport Beach, CA |
|
11/26/2005 |
|
|
|
Details |
|
Bio-Anatomic Radiation Treatment Planning for Newly Diagnosed
Glioblastoma multiforme |
|
Winston-Salem, NC |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Chemosensitivity for Malaysian Brain tumors |
|
Kelantan, Malaysia, MALAYSIA |
|
11/26/2005 |
|
|
|
Details |
|
Intra-arterial carboplatin for supratentorial brain tumors |
|
Fort Worth, TX |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Use of interferon for the treatment of gliomas of the brain and spine. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/26/2005 |
|
|
|
Details |
|
Aggresive emergency tumour debulking and craniectomy for patients with tumours of more than 80ml and glasgow coma scale of less than 8. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Chemosensitivity assay for malignant brain tumors |
|
Huntington Beach, CA |
|
11/26/2005 |
|
|
|
Details |
|
Computer assisted minimally invasive image guided surgery for improved resection of malignant brain tumors and frameless stereotactic brain biopsies For Deep Brain Tumors. |
|
Smithtown, NY |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Concurrent Temozolomide and Radiotherapy Followed By Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid For Patients With Newly Diagnosed Glioblastoma And Other Malignant Gliomas |
|
New York, NY |
|
11/26/2005 |
|
|
|
Details |
|
Conventional Radiation Therapy + Thalidomide for Supratentorial Glioblastoma |
|
Winston-Salem, NC |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Dose Escalation Study of RT Using 3-Dimensional Treatment Planning for Newly Diagnosed GBM |
|
Winston-Salem, NC |
|
11/26/2005 |
|
|
|
Details |
|
Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without
subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors |
|
New York, NY |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Intraoperative navigation in neurosurgical patients |
|
Boston, MA |
|
11/26/2005 |
|
|
|
Details |
|
Phase I study of Photodynamic Therapy with porfimer sodium for refractory brain tumors |
|
Milwaukee, WI |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Temodar and Escalating Doses of Oral VP-16 for Patients with Recurrent Malignant Glioma |
|
Rochester, NY |
|
11/26/2005 |
|
|
|
Details |
|
Reliable Imaging Diagnosis of Recurrent Brain Tumor |
|
Winston-Salem, NC |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Frameless Computer Assisted Stereotactic Surgery for Resection of Brain Tumors in Adults and Children |
|
Rockford, IL |
|
11/25/2005 |
|
|
|
Details |
|
Frameless Computer Guided Stereotactic Sugery for Resection of Brain Tumors in Adults and Children |
|
Rockford, IL |
|
11/25/2005 |
|
|
|
|
|
Details |
|
Accelerated Radiotherapy and Temodar in Adults with Newly Diagnosed Glioblastoma Multiforme - a Pilot Study |
|
Rochester, NY |
|
11/25/2005 |
|
|
|
Details |
|
Brain tumor surgery using a compact intraoperative MRI
|
|
Manhasset, NY |
|
11/25/2005 |
|
|
|
|
|
Details |
|
Accelerated Radition Therapy With ARCON For Glioblastomas |
|
Lanne, SWITZERLAND |
|
11/25/2005 |
|
|
|
Details |
|
A Phase II Study of BCNU in Combination with Pentoxifyline for Patients with Newly Diagnosed Glioblastoma Multiforme |
|
Syracuse, NY |
|
11/24/2005 |
|
|
|
|
|
Details |
|
Long-term survivors of high grade gliomas. |
|
Salt Lake City, UT |
|
11/24/2005 |
|
|
|
Details |
|
A trial of Dalteparin low molecular weight heparin for primary prophylaxis of venous thromboembolism in brain tumor patients. |
|
Salt Lake City, UT |
|
11/24/2005 |
|
|
|
|
|
Details |
|
Use of Hight Dose Tamoxifen For Patients Who Refuse Surgery For meningiomas and Gliomas. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/24/2005 |
|
|
|
Details |
|
Gene Therapy Of Malignant Gliomas: A Pilot Study of Vaccination With Autologous Glioma-Lysate And Dendritic Cells Admixed With IL-4 Transduced Fibroblasts To Elicit An Immune Response. |
|
Pittsburgh, PA |
|
11/21/2005 |
|
|
|
|
|
Details |
|
Oral ST 1481 in adults with Malignant Glioma: a Phase I-II Clinical Trial |
|
Providence, RI |
|
11/21/2005 |
|
|
|
Details |
|
Fractionated Stretactic Radiotherapy Boost with weekly Paclitaxel in malignant gliomas. |
|
Brooklyn, NY |
|
11/20/2005 |
|
|
|
|
|
Details |
|
Phase I Brachytherapy Dose Escalating Study Using the Proxima Therapeutics, Inc. GliaSIte RTS in Patients with Recurrrent Malignant Gliomas |
|
Winston-Salem, NC |
|
11/20/2005 |
|
|
|
Details |
|
Phase I/II trial of Temodar and escalating doses of Oral VP-16 for patients with recurrent malignant gliomas. |
|
Durham, NC |
|
11/20/2005 |
|
|
|
|
|
Details |
|
Phase II treatment with Irinotecan (CPT-11) plus Celebrex® of adults with primary malignant glioma. |
|
Durham, NC |
|
11/20/2005 |
|
|
|
Details |
|
Streotactic Radiosurgery for brain lesions |
|
Brooklyn, NY |
|
11/20/2005 |
|
|
|
|
|
Details |
|
"Head Start" chemotherapy protocol for children less than 10 years old with newly diagnosed high grade primary brain tumors with intent to eliminate irradiation and abbreviate total duration of treatment to 6 months with resultant improved cure rate and quality of survival. |
|
Los Angeles, CA |
|
11/20/2005 |
|
|
|
Details |
|
Intraoperative MRI for brain tumors |
|
Boston, MA |
|
11/20/2005 |
|
|
|
|
|
Details |
|
Stereotactic Radiosurgery for High Grade Gliomas, for Lesions <4cm AND >4cm.
Brachytherapy for Lesions >4cm |
|
Hackensack, NJ |
|
11/20/2005 |
|
|
|
Details |
|
Activation of A Pilot Comparison Bioavailability Study of Oral and Intravenously Administered Temozolomide (Temodar) in patients with primary CNS malignancies. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Phase I/II trial of ZD1839 (Iressa) in pediatric patients newly diagnosed with brain stem tumors or incompletely resected supratentorial malignant gliomas. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
Details |
|
Phase II study of VNP40101M for the treatment of adults with newly diagnosed or recurrent malignant glioma. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Phase I treatment with Irinotecan (CPT-11) plus Temozolomide (Temodar) of children with primary recurrent malignant brain tumors. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
Details |
|
Phase I trial of Oral Topotecan plus Temodar in the treatment of patients with recurrent/progressive malignant gliomas. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Phase I, open-label, 2-arm dose escalation study of Imatinib Mesylate (Gleevec) in combination with Temozolomide (Temodar)in patients with glioblastoma multiforme and gliosarcoma. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
Details |
|
Phase II trial of Gleevec plus hydroxyurea in the treatment of patients with malignant glioma |
|
Durham, NC |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Pilot study of genetic and environmental Risk and outcome for newly diagnosed brain tumor patients and controls. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
Details |
|
Pilot trial of Innohep (Tinzaparin) Low Molecular Weight Heparin for primary prophylaxis of venous thromboembolism in brain tumor patients. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
|
|
, England |
|
11/13/2005 |
|
|
|
Details |
|
A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection
|
|
, Germany
, Germany
, Germany
, Netherlands
Brussels, Belgium
Germany,
Marseille, France
Nice, 06002, France
Phoenix, AZ
Iowa City, IA
Lexington, KY
Boston, MA
Minneapolis, MN
St. Louis, MO
New York, NY
Memphis, TN
Milwaukee, WI |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Antineoplaston Therapy in Treating Children With Brain Tumors
|
|
Houston, TX |
|
11/11/2005 |
|
|
|
Details |
|
Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma
|
|
Boston, MA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Malignant Glioma (Glioblastoma multiforme, Gliosarcoma, Anaplastic astrocytoma, PNET, Oligodendroglioma)
|
|
Paterson, NJ
New York, NY |
|
11/11/2005 |
|
|
|
Details |
|
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors |
|
, CANADA
,
Los Angeles, CA
Palo Alto, CA
Washington, DC
Indianapolis, IN
Boston, MA
Minneapolis, MN
Rochester, MN
Jackson, MS
New York, NY
Syracuse, NY
Cincinnati, OH
Portland, OR
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Dallas, TX
Houston, TX
Seattle, WA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors |
|
Washington, DC
Chicago, IL
Boston, MA
Durham, NC
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
11/11/2005 |
|
|
|
Details |
|
A Phase I Gliadel and Escalating Doses of Intravenous O6-Benzylguanine Trial in Patients with Recurrent Malignant Glioma |
|
Baltimore, MD |
|
11/09/2005 |
|
|
|
|
|
Details |
|
Study of Lenalidomide and XRT in Patients with Newly Diagnosed Glioblastoma Multiforme |
|
Boston, MA
Boston, MA
Boston, MA |
|
11/09/2005 |
|
|
|
Details |
|
Phase I, Gliadel® & Escalating Doses of Intravenous O6-Benzylguanine in People with Recurrent Malignant Glioma
|
|
Winston-Salem, NC |
|
11/09/2005 |
|
|
|
|
|
Details |
|
Phase I/II, two-arm, multicenter, dose escalation study of Oral AEE788 administered on a continuous once daily dosing schedule in adult patients with recurrent or relapsing glioblastoma. |
|
Los Angeles, CA
Durham, NC |
|
11/07/2005 |
|
|
|
Details |
|
An Open-label, Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B MAB (COTARA) for the Treatment of Glioblastoma Multiforme (GBM) at 1st of 2nd Relapse |
|
Baltimore, MD |
|
11/06/2005 |
|
|
|
|
|
Details |
|
Boron Neutron Capture Therapy (BNCT) to Treat Anaplastic Astrocytoma or Glioblastoma That Has Progressed Following Radiotherapy |
|
Helsinki, Finland |
|
11/06/2005 |
|
|
|
Details |
|
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment |
|
, Puerto Rico
Fort Myers, FL
Gainesville, FL
Jacksonville, FL
Pensacola, FL
St. Petersburg, FL
Tampa, FL
West Palm Beach, FL
Augusta, GA
Indianapolis, IN
Grand Rapids, MI
Syracuse, NY
Akron, OH
San Antonio, TX
San Antonio, TX
Temple, TX
Richmond, VA
Green Bay, WI |
|
11/06/2005 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Birmingham, AL
Scottsdale, AZ
Jacksonville, FL
Rochester, MN |
|
11/06/2005 |
|
|
|
Details |
|
NCCTG Phase 2 Trial of CCI-779 (Temsirolimus) in Recurrent Glioblastoma Multiforme |
|
Mobile , AL |
|
11/06/2005 |
|
|
|
|
|
Details |
|
Phase I study of Cilengitide in children with refractory brain tumors. |
|
Durham, NC |
|
11/06/2005 |
|
|
|
Details |
|
Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA
Boston, MA
Ann Arbor, MI
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
11/06/2005 |
|
|
|
|
|
Details |
|
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
|
|
Iowa City, IA |
|
11/06/2005 |
|
|
|
Details |
|
Randomized Phase 2 with CpG-ODN in Malignant Glioblastoma |
|
Paris, France
Paris, France |
|
11/06/2005 |
|
|
|
|
|
Details |
|
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma |
|
Memphis, TN |
|
11/06/2005 |
|
|
|
Details |
|
Radiosurgery with the Varian Trilogy system for benign or malignant brain tumors |
|
Mobile , AL |
|
11/06/2005 |
|
|
|
|
|
